• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • Investor Information
    • News & Articles
    • Careers
  • About Us
    • Our Values
    • Our Story
    • Our Team
    • Board of Directors
  • Contact

Exopharm Ltd

  • All
  • EVs 101
  • News
  • Opinion Articles
  • Talks & Webinars
  • The Life of Science
  • Whitepapers

March 5, 2021 By Exopharm Ltd

The Life of Science – Aislinn

With International Women’s Day around the corner, we share with you our third profile video featuring Aislinn Treloar, our multi-talented Business Development Manager. As an inspiring and humble leader, Aislinn has played a pivotal role in advancing our technologies through collaborations and partnerships and is one of the many amazing women who work at Exopharm.  

Filed Under: The Life of Science

February 25, 2021 By Exopharm Ltd

Exopharm preps for great LEAP forward as world catches onto exosome promise

“People have begun to understand that our destiny is not only in our hands, it is in the hands of the entire exosome research community, and everybody who is trying to develop exosome medicines, because there’s no technology that has been demonstrated that can produce thousands, much less tens of thousands or hundreds of thousands […]

Filed Under: News

February 19, 2021 By Exopharm Ltd

Early Careers in Science Webinar

Early Careers in Science Webinar – Hosted by Exopharm 18 February 2021 12-12.45pm AEDT Choosing a career path can be daunting, and we understand this.  Aimed at high school students, this free webinar provided some insight into a career in science and featured speakers from Exopharm who are passionate about helping students embrace this field. […]

Filed Under: News, Talks & Webinars

February 16, 2021 By Exopharm Ltd

Exopharm presents at BIO CEO & Investor Digital Conference

We presented at the BIO CEO & Investor Digital Conference which is taking place from 16-18 February. Our Chief Commercial Officer, Dr. Chris Baldwin, provided insight into our company,  exosomes in general and the technologies we are using to bring exosome therapeutics to the world. You can find the slide deck here.

Filed Under: News, Talks & Webinars

February 4, 2021 By Exopharm Ltd

The Life of Science – Sam

Today we share with you the second profile video in our series called “The Life of Science”. This video features Sam Law, our Process Engineer. Sam drives the execution of all things related to exosome isolation and manufacturing. He is a true team player and a tinkerer by nature.  

Filed Under: News, The Life of Science

February 2, 2021 By Exopharm Ltd

Edison Open House – Global Healthcare 2021 Interview

Watch our interview at the Edison Group Open House: Global Healthcare 2021 Conference.

Filed Under: News, Talks & Webinars

December 30, 2020 By Exopharm Ltd

The Life of Science – Karen

The pandemic of 2020 affected how we do our science, how we live our lives, how we interrelate and how we advance exosome medicine in a world that seems to be standing still. As a thank you to all of our staff, their families, our peers, our investors and our collaborators for your belief, hard […]

Filed Under: News, The Life of Science

November 18, 2020 By Exopharm Ltd

Presentation recording – Exosome TX Summit

Producing EVs at the Clinical Scale On November 11, we presented at the Exosome Based Therapeutic Development Digital Summit. At this key exosome industry event, we had the opportunity to highlight our LEAP technology, the team’s accomplishments and our commitment to collaboration to advance the development of all exosome therapeutics. Our Chief Commercial Officer, Dr […]

Filed Under: News, Talks & Webinars

November 13, 2020 By Exopharm Ltd

Exopharm’s LEAP technology a breakthrough in exosome therapeutics

“The biggest problem is to purify the EVs from their source and to eliminate the contaminants, and not damage the EVs,” says Managing Director and founder Dr Ian Dixon. One of the great things about our LEAP technology and process is that it is scalable. You can read the full Stockhead article here.

Filed Under: News

November 11, 2020 By Exopharm Ltd

Exopharm to Present at Key Exosome Industry Event

Chief Commercial Officer, Dr Chris Baldwin, will present to the Exosome Based Therapeutic Development Digital Summit on 11 November (9:00 AM US Eastern Time, 1.00 AM AEDT), the first day of the two-day event. You can find the slide deck here.  

Filed Under: News

November 6, 2020 By Exopharm Ltd

Webinar Nov 2020 – Behind the scenes with our scientists

Our science is too important to leave to just the scientists. On November 5, Dr Balarka Banerjee and Dr Kartini Asari explained some of the advances Exopharm is making. This science update forms part of our ‘Behind the Scenes’ webinar series.   Stem Cells: Exosome Factories Dr. Balarka Banerjee, Cell Development Manager Exopharm’s unique LEAP […]

Filed Under: News, Talks & Webinars

October 23, 2020 By Exopharm Ltd

Exopharm has just dosed its first patient in a wound-healing study

“With a successful outcome from PLEXOVAL II, Exopharm will be well-positioned to initiate Phase 2 studies with off-the-shelf Plexaris and Phase 1 studies with our mesenchymal stem cell EV product Cevaris,” said Angus Tester, Head of Product Evaluation. You can read the full Stockhead article here.   

Filed Under: News

October 15, 2020 By Exopharm Ltd

Health Kick Podcast: This biopharma company may be the world’s only exosome-based player

Yesterday, Chief Commercial Officer Chris Baldwin sat down with Stockhead’s resident health and biotech expert Tim Boreham for the latest episode of The Health Kick Podcast. They discuss the potential of exosomes to transform healthcare, and our journey to commercialising our exosome therapeutics. Click below to listen. You can find the full post here. 

Filed Under: News, Talks & Webinars

October 7, 2020 By Exopharm Ltd

How mRNA vaccines could defeat the novel coronavirus

How mRNA vaccines could defeat the novel coronavirus   Head of Innovation Andy Coley spoke with Stockhead about the potential of mRNA for fighting COVID-19, including Moderna’s vaccine candidate and Fortrexo, our engineered EV approach. You can find the full article here.  

Filed Under: News

September 24, 2020 By Exopharm Ltd

ShareCafe – Hidden Gems Webinar

ShareCafe’s “Hidden Gems” Webinar 18 Sept 2020 Chief Commercial Officer Chris Baldwin provides updates on Exopharm’s Technology and Naive EV programs, including the addition of Alison Mew to the senior leadership and the progress on Exopharm’s second clinical trial.  

Filed Under: News, Talks & Webinars

September 3, 2020 By Exopharm Ltd

Webinar Sept 2020 – Science Update

Behind the Scenes with our Scientists Recently, there has been a variety of updates about the company’s business progress and accomplishments. This webinar provided a closer look at some of science and technology behind our most recent advances, Fortrexo CoV™ and Exoria™.   RNAi’s to Stop Coronavirus Dr Karen Holden, Head of Translation Exopharm has […]

Filed Under: News, Talks & Webinars

September 1, 2020 By Exopharm Ltd

Exopharm Raises $10 million

Exopharm has announced a placement of shares to raise $10 million. Canary Capital, the manager of the placement, and its directors have elected to take the majority of their fees in shares. “In Exopharm, Canary has identified an Australian company with proprietary technology that can compete on the world stage”, says Paul Hart, Executive Director […]

Filed Under: News

August 20, 2020 By Exopharm Ltd

Exopharm’s Big Idea Heading For A Big Business In EV Medicines

“As a serial biotechnology entrepreneur, Dr Dixon doesn’t just develop technologies or products – he wants to build long-lasting businesses based upon big ideas.” Written by our Chief Commercial Officer Chris Baldwin, this Sharecafe article explains Dr Dixon’s big idea back in 2013 and how it led to the foundation of Exopharm. Today, Exopharm is […]

Filed Under: News

August 11, 2020 By Exopharm Ltd

Webinar July 2020 – Shareholder Update

Exopharm CCO Dr Chris Baldwin gives a shareholder update on the ‘Morning Twilight Briefing’ webinar series hosted by Monsoon Communications. Chris discusses Exopharm’s key development areas and provides an overview of the company’s engineered EV technology.  

Filed Under: News, Talks & Webinars

August 11, 2020 By Exopharm Ltd

A Quest Grounded in Commercial Basics

Biotech Daily’s Tim Boreham likes Exopharm’s focus: “Given the scientifically complex nature of Exopharm’s quest to develop exosomes into therapeutics, it’s good to see that founder and chief executive Ian Dixon hasn’t lost sight of the commercial basics.” Read the full article here.  

Filed Under: News

July 27, 2020 By Exopharm Ltd

MST Access Initiates Coverage of Exopharm

MST Access, a division of MST Financial which provides institutional-grade research for small and medium cap companies, has initiated coverage of Exopharm Ltd (ASX: EX1). Read the full report here.

Filed Under: News

June 9, 2020 By Exopharm Ltd

Their Curiosity and Enthusiasm are Infectious

Their Curiosity and Enthusiasm are Infectious… Recently Chief Commercial Officer Chris Baldwin sat down with StockPal to discuss the CEO mindset. Read Chris’ thoughts on Exopharm, measuring success, and the future of exosome medicines. Read the full article on Stockpal Asia.  

Filed Under: News

The Exopharm BD Team

June 5, 2020 By Exopharm Ltd

BD Team Welcomes Partners

BD Team Welcomes Partners The Business Development team is excited to be participating in the virtual “Bio Digital Partnering Convention 2020.”  With over 30 meetings with potential business partners from around the globe already planned, they are eager to find partners to help us in our mission to bring exosome medicines to the world. Other […]

Filed Under: News

June 1, 2020 By Exopharm Ltd

Exopharm Webinar May 2020 – Our Strategic Response to COVID-19

Exopharm Webinar May 2020 – Our Strategic Response to COVID-19 Exopharm updates the public on its recent progress and activities. Hosted by Jason Watson, Chair of Exopharm, Ian Dixon (CEO), Gregor Lichtfuss (COO) and Chris Baldwin (CCO) discuss how COVID-19 has affected operations and strategies. The application of Exopharm’s engineered exosome program, Fortrexo, is discussed, […]

Filed Under: News, Talks & Webinars

Exopharm Sport

September 4, 2019 By Exopharm Ltd

Understanding and Sharing our Progress at Exopharm

Exopharm: Preparation, Demonstration and Reward As a biotech stock, order or to maximise the financial returns from our technologies and products there are a number of aspects to the business of Exopharm. As a headline, we see ourselves as world leaders in a new type of regenerative medicine – harnessing exosomes as the ‘secret sauce’ […]

Filed Under: Opinion Articles

Footer

Resources

  • ASX Announcements
  • Investor Information
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2021 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media